par Van Vooren, Jean-Paul 
;Schepers, Kinda
Référence Revue médicale de Bruxelles, 34, 4, page (301-305)
Publication Publié, 2013-09
;Schepers, Kinda Référence Revue médicale de Bruxelles, 34, 4, page (301-305)
Publication Publié, 2013-09
Article révisé par les pairs
| Résumé : | Rapid identification using bacteriological methods and adequate treatment of active tuberculosis cases are the most important objective of any tuberculosis activity but, in order to eliminate the disease, another important component of tuberculosis control is to reduce the vast reservoir of latent tuberculosis infections. Tuberculin skin test and interferongamma release assays are designed to identify immune response against mycobacterial antigens. Both tests are accurate to detect latent but not active forms of tuberculosis. Interferongamma release assays have higher specificity than tuberculin skin testing in BCG-vaccinated populations particularly if BCG was administered after 1 year of age. Both tests perform poorly to predict risk for progression to active tuberculosis. Screening should therefore be limited to situations with a clear likelihood of transmission after contact, taking account of the infectiousness of the index case and the intensity of exposure, or to those with a great probability of developing tuberculosis : young children and immunocompromised persons. |
